Examples of using Hypercalcaemia in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Treatment of tumour-induced hypercalcaemia TIH.
Hypercalcaemia, hypermagnesaemia, hypernatraemia, weight decreased.
Overdose leads to hypercalciuria and hypercalcaemia.
Treatment of tumour-induced hypercalcaemia with or without metastases.
Overdose can lead to hypervitaminosis and hypercalcaemia.
H05B A01 Hypercalcaemia of malignancy and Paget's Disease.
A limited number of patients(50 patients)have received a second infusion for hypercalcaemia.
Chronic overdose with resulting hypercalcaemia can cause vascular and organ calcification.
In a clinical study of healthy adults a 4000 IU daily dose of vitamin D3 for up to five months was not associated with hypercalciuria or hypercalcaemia.
Marked hypercalcaemia may be evidence of hidden hyperparathyroidism.
The most likely cause of leukogram changes and hypercalcaemia was neoplasia.
Hypercalcaemia Hydrochlorothiazide stimulates renal calcium reabsorption and may cause hypercalcaemia.
This includes fractures, spinal compression,bone disorders needing radiotherapy or surgery, and hypercalcaemia high levels of calcium in the blood.
In study CA209017, hypercalcaemia was more frequently reported in the nivolumab group(31/130, 24%) than in the docetaxel group 9/124, 7.
Hypokalaemia, increased appetite, hypophosphataemia, decreased appetite, dehydration, gout,hyperuricaemia, hypercalcaemia, hyperglycaemia, hyponatraemia.
In hypercalcaemia, the recommended starting dose is 100 IU every 6 to 8 hours by subcutaneous or intramuscular injection.
This includes fractures(breaks in the bone), spinal compression(when the spinal cord is compressed by the bone), bone disorders needing radiotherapy(treatment with radiation)or surgery, and hypercalcaemia high levels of calcium in the blood.
In case of chronic overdose where hypercalcaemia is present, the initial therapeutic step is hydration with saline solution.
In Paget' s disease(a bone disease that involves bone destruction andregrowth that causes deformity), and in hypercalcaemia(increased blood calcium) caused by cancer.
In most patients with severe hypercalcaemia(albumin-corrected serum calcium*≥ 3 mmol/ l or≥ 12 mg/ dl) 4 mg is an adequate single dosage.
Increased AST, increased ALT, increased alkaline phosphatase, increased lipase, increased amylase, hypocalcaemia, increased creatinine, lymphopaenia, leucopoenia, thrombocytopaenia,anaemia, hypercalcaemia, hyperkalaemia, hypokalaemia, hypomagnesaemia, hyponatraemia.
Treatment of tumour-induced hypercalcaemia- added to 500 ml isotonic sodium chloride solution or 500 ml 5% dextrose solution and infused over 2 hours.
This includes fractures(breaks in the bone), spinal compression(when the spinal cord is compressed by the bone), bone disorders needing radiotherapy(treatment with radiation)or surgery, and hypercalcaemia high levels of calcium in the blood.
Metabolic acidosis, diabetes mellitus, hyponatraemia, hypercalcaemia, hyperuricaemia, hypoalbuminaemia, cachexia, failure to thrive, gout, hypophosphataemia, hyperphosphataemia, increased appetite.
Bondronat is used:• as an infusion or as a tablet to prevent‘ skeletal events'(broken bones or bone complications requiring treatment) in patients with breast cancer and bone metastases(when the cancerhas spread to the bone);• as an infusion to treat hypercalcaemia(high levels of calcium in the blood) caused by tumours.
Clinical trial results in thetreatment of TIH Clinical studies in tumour-induced hypercalcaemia(TIH) demonstrated that the effect of zoledronic acid is characterised by decreases in serum calcium and urinary calcium excretion.
Hypercalcaemia has been shown to occur occasionally in infant populations receiving periodic administration of very high doses of vitamin D(15 mg, every 6 months) as a prophylaxis against rickets, and 25-(OH)D levels in the blood of these infants reach values similar to those found in patients with obvious vitamin D intoxication'·5.
Parareg has also been studied in a study involving 46 patients with hypercalcaemia, including 29 with parathyroid carcinoma and 17 with primary hyperparathyroidism who could not have their parathyroid glands removed or in whom surgery to remove the parathyroid glands was not effective.
Contraindications Patients with hypercalcaemia, metastatic calcification, hyperphosphataemia(except when occurring with hypoparathyroidism) or hypermagnesaemia, vitamin D toxicity or hypersensitivity to the vitamin D or its analogues cannot be treated by Alfacip.
Clinical studies in hypercalcaemia of malignancy demonstrated that the inhibitory effect of ibandronic acid on tumour-induced osteolysis, and specifically on tumour-induced hypercalcaemia, is characterised by a decrease in serum calcium and urinary calcium excretion.